However, some studies have reported exceptionally high CD133-positive (20%–60%) fractions in some human GBMs and/or glioma cell lines [2, 38, 41], according to immunohistochemical findings demonstrating that many GBMs contain more than 25% CD133-positive cells [42]. The gene discussed is PROM1; the disease is central nervous system cancer.